A95.0
Sylvatic yellow fever
Clinical Classification Guidelines
Inclusion Terms
- Jungle yellow fever
Medical Intelligence & Overview
Sylvatic yellow fever, also known as jungle yellow fever, is a viral disease transmitted primarily through the bites of infected mosquitoes that breed in forested areas. It is a form of yellow fever that occurs mainly in the wilderness or jungle regions, affecting both non-human primates and humans. The disease is caused by the yellow fever virus, which belongs to the Flaviviridae family. Although it is less common than urban yellow fever, sylvatic yellow fever can pose health risks in certain regions, especially where there is close contact with jungle habitats.
Causes & Symptoms
Clinical Causes: Transmission of the yellow fever virus through the bite of infected female mosquitoes, mainly Aedes and Haemagogus species. Contact with infected non-human primates that serve as reservoirs of the virus. Infection occurs mainly in jungle or forested areas where humans venture into or reside near wildlife habitats.
Key Symptoms: Fever, chills, and headache Muscle aches and back pain Nausea and vomiting Weakness and fatigue In some cases, jaundice (yellowing of the skin and eyes) Liver and kidney dysfunction in severe cases Bleeding tendencies may develop in advanced stages
Diagnostic & Treatment
Diagnosis Path: Diagnosing sylvatic yellow fever involves a combination of clinical assessment and laboratory testing. Blood tests can detect the presence of the yellow fever virus or specific antibodies. Travel history to jungle regions and potential exposure to mosquito bites are crucial for diagnosis. In some cases, viral isolation or PCR (polymerase chain reaction) tests may be employed to confirm infection. Due to similarities with other febrile illnesses, differential diagnosis is often necessary to exclude other diseases like malaria, dengue, or other viral hemorrhagic fevers.
Treatment Protocols: There is no specific antiviral treatment for yellow fever. Management focuses on supportive care, which includes Rest, hydration, and pain relief. Patients with severe illness may require hospitalization to monitor and treat complications such as bleeding, organ failure, or dehydration. Vaccination pre-exposure is the most effective method of prevention, especially for travelers planning to visit endemic regions. In outbreak settings, mosquito control measures and avoidance of mosquito bites are essential to limit disease spread.
Clinical Advice & FAQs
Billing Guidance
Is A95.0 a billable ICD-10 code?
Yes, A95.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report A95.0?
Clinical documentation must specify the nature of Sylvatic yellow fever and any associated comorbidities for accurate reporting.
Cite this Clinical Reference